Cargando…

Epigenetic inactivation of ST6GAL1 in human bladder cancer

BACKGROUND: Posttranslational protein modifications are known to modulate key biological processes like proliferation and apoptosis. Accumulating evidence shows that ST6GAL1, an enzyme that catalyzes the transfer of sialic acid onto galactose-containing substrates, is aberrantly expressed in various...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antony, Pia, Rose, Michael, Heidenreich, Axel, Knüchel, Ruth, Gaisa, Nadine T, Dahl, Edgar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265431/ https://www.ncbi.nlm.nih.gov/pubmed/25465919 http://dx.doi.org/10.1186/1471-2407-14-901

Ejemplares similares

The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells
por: Rose, Michael, et al.
Publicado: (2021)

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
por: Wiesmann, Frank, et al.
Publicado: (2009)

Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR
por: Chughtai, Ahmed Ali, et al.
Publicado: (2022)

Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
por: Mijnes, Jolein, et al.
Publicado: (2018)

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy
por: Schnitzler, Tician, et al.
Publicado: (2020)

Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli
por: Ortiz-Soto, Maria Elena, et al.
Publicado: (2016)

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
por: Garczyk, Stefan, et al.
Publicado: (2018)

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications
por: Barth, Isabella, et al.
Publicado: (2018)

ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer
por: Rose, Michael, et al.
Publicado: (2020)

SWI/SNF Alterations in Squamous Bladder Cancers
por: Achenbach, Fabian, et al.
Publicado: (2020)

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2008)

Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion
por: Li, Jiaxuan, et al.
Publicado: (2022)

Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer
por: Wucherpfennig, Sophie, et al.
Publicado: (2021)

Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2023)

Role of ST6GAL1 and ST6GAL2 in subversion of cellular signaling during enteroaggregative Escherichia coli infection of human intestinal epithelial cell lines
por: Chandel, Shipra, et al.
Publicado: (2023)

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2022)

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
por: Morsch, Ronja, et al.
Publicado: (2020)

ST6GAL1: A key player in cancer
por: Garnham, Rebecca, et al.
Publicado: (2019)

Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase
por: Holdbrooks, Andrew T., et al.
Publicado: (2020)

ST6Gal1: Oncogenic signaling pathways and targets
por: GC, Sajina, et al.
Publicado: (2022)

ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
por: Videira, Paula A, et al.
Publicado: (2009)

Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli
por: Skretas, Georgios, et al.
Publicado: (2009)

Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue
por: Zafrakas, Menelaos, et al.
Publicado: (2008)

Role of GalNAc4S-6ST in Astrocytic Tumor Progression
por: Kobayashi, Tatsuya, et al.
Publicado: (2013)

Phylogenetic-Derived Insights into the Evolution of Sialylation in Eukaryotes: Comprehensive Analysis of Vertebrate β-Galactoside α2,3/6-Sialyltransferases (ST3Gal and ST6Gal)
por: Teppa, Roxana E., et al.
Publicado: (2016)

Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells
por: Wang, Yu-Chieh, et al.
Publicado: (2015)

Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
por: Jung, Max, et al.
Publicado: (2023)

Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer
por: Smithson, Mary, et al.
Publicado: (2022)

α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth
por: GC, Sajina, et al.
Publicado: (2022)

Probing the CMP‐Sialic Acid Donor Specificity of Two Human β‐d‐Galactoside Sialyltransferases (ST3Gal I and ST6Gal I) Selectively Acting on O‐ and N‐Glycosylproteins
por: Noel, Maxence, et al.
Publicado: (2017)

Cleavage of ST6Gal I by Radiation-Induced BACE1 Inhibits Golgi-Anchored ST6Gal I-Mediated Sialylation of Integrin β1 and Migration in Colon Cancer Cells
por: Lee, Minyoung, et al.
Publicado: (2012)

Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes
por: Suzuki, Hitoshi, et al.
Publicado: (2014)

A Golgi-associated redox switch regulates catalytic activation and cooperative functioning of ST6Gal-I with B4GalT-I
por: Hassinen, Antti, et al.
Publicado: (2019)

ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
por: Schultz, Matthew J, et al.
Publicado: (2013)

Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells
por: Zhang, Xiaopeng, et al.
Publicado: (2016)

Blood-Borne ST6GAL1 Regulates Immunoglobulin Production in B Cells
por: Irons, Eric E., et al.
Publicado: (2020)

Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness
por: Hait, Nitai C., et al.
Publicado: (2022)

Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS
por: Geisler, Cordelia, et al.
Publicado: (2015)

Involvement of ST6Gal I‐mediated α2,6 sialylation in myoblast proliferation and differentiation
por: Vergé, Caroline, et al.
Publicado: (2019)

Diagnostic and Prognostic Implications of FGFR3(high)/Ki67(high) Papillary Bladder Cancers
por: Geelvink, Mirja, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q6ecpftgtid927a5t5psv350c1